National and Kapodistrian University of Athens
Μελέτη της κλινικής σημασίας του ελεύθερου DNA (Free-DNA) στο περιφερικό αίμα σε διάφορες παθολογικές καταστάσεις
Abstract
dc:descriptionCirculating nucleic acids have been detected in the plasma of normal and diseased individuals since 1948 (cell free DNA, cell free RNA) and although the exact mechanisms that underlie the release of nucleic acid molecules in the peripheral circulation are not yet fully understood, cell death -through apoptosis and necrosis- is considered the major contributor of their rise in plasma according to findings reported mainly in cancer studies. Elevated cell free DNA levels may serve as an indicator of clinical severity in various pathological conditions such as autoimmune diseases, tissue injury and stroke and they have been correlated with the degree of tissue damage and the severity of post traumatic organ failure thus granting this new biomarker a potential prognostic value for risk stratification of trauma patients. The objective of this study was to investigate the clinical significance of cell-free DNA kinetics in patients with an acute myocardial infarction (AMI), in acute and chronic inflammation in exhaustive exercise and in juvenile rheumatoid arthritis. For the purposes of the present study, we developed a sensitive, reproducible and reliable quantitative real- time PCR (q RT-PCR) to measure cell-free DNA extracted from plasma. The method’s reproducibility and accuracy were assessed by calculating the interassay and intrassay coefficient of variation (CV%). Serial cell-free DNA level determinations were performed by quantitative Real-Time PCR in 47 AMI patients once daily during hospitalization (235 samples) and once in 100 healthy subjects (to establish the normal reference range). In addition, blood samples were obtained from 15 male athletes, participating in the ultradistance foot race of the 246 Km “Spartathlon”, in order to measure plasma interleukin-6 (IL-6), the serum inflammatory markers C-reactive protein (CRP) and serum amyloid A (SAA), and the tissue cell-free plasma DNA, before, at the end, and 48 h after the end of the race. Moreover, cell-free plasma DNA was measured along with C-reactive protein (CRP), creatine kinase (CK), and uric acid (UA) in 17 recreationally trained men participating in a 12-week resistance training regimen (8 resistance multi-joint exercises selected to stress the entire musculature). Finally, cell-free DNA was measured in children who have been diagnosed with juvenile arthritis upon diagnosis and after therapy administration. Statistical analysis of the measurements showed that cell-free DNA concentrations are significantly higher in patients throughout hospitalization compared to healthy subject levels (P<0.001). The median maximum cell-free DNA concentration was 3.5-fold higher (Mann Whitney P=0.0035) in 20/47patients with complicated post AMI course (1719.7, range 117.32-4996212.1 GenEq/ml plasma) compared with 27/47 patients without complications (492.9, range 56.43-4715.15 GenEq/ml plasma). Substantial differences exist between cell-free DNA concentrations measured on tpre (the day before the complication) and tc (the day the complication occurred) as well as tpost (the day after the complication) in group I whereby cell-free DNA rises significantly in tc and remains elevated in tpost (tpre vs. tc, 2.445 vs. 2.965, P=0.0171 and tpre vs. tpost 2.445 vs. 2.913, P=0.023). In addition, cell-free DNA could serve as a prognostic marker in heart failure (LVEF<40%). In the ‘Spartathlon’ paradigm of exhaustive exercise, IL-6, CRP, SAA and free plasma DNA levels markedly increased (by 8000-, 152- 108- and 10-fold, respectively) over the baseline at the end of the race. Cell-free DNA concentrations were elevated in AMI patients compared to healthy subjects, rise significantly when complications occur and have a potential clinical value in monitoring patient progress during hospitalization. Our findings suggest that the kinetics of cell-free DNA released in the peripheral circulation reflect the damage of the myocardium during the post AMI period. In the chronic inflammation model, cell-free DNA concentrations correlated with training volume whereas CRP, UA and CPK did not. Statistical analysis of the data obtained from the juvenile arthritis patients showed that significant differences exist between the patient and healthy control group. Cell-free DNA concentrations were elevated in AMI patients compared to healthy subjects, rise significantly when complications occur and have a potential clinical value in monitoring patient progress during hospitalization. This study also demonstrates that, after chronic excessive resistance exercise, plasma DNA concentrations increase in proportion to training load, suggesting that cell-free DNA may be a sensitive marker for overtraining-induced inflammation. In conclusion, cell-free DNA should be further studied to reveal its potential clinical use as a marker of the inflammatory processes, which play a role in the development of heart failure and death.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Destouni, Aspasia
- Δεστούνη, Ασπασία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27483